W. Robert Friedman, Jr.
Robert is Managing Director of Healthcare at Dresner Partners. He has over 35 years of health care investment banking and research experience. He joined Northeast Securities as a director in February, 2010 from Burnham Securities, where he had been the co‐head of their health care investment banking practice from 2003 to 2010. Prior to joining Burnham, Robert was with Dominick & Dominick, where he ran their healthcare practice. Robert spent five years with Flemings, the British merchant bank, where he headed the health care industry group, working extensively with both U.S. and international healthcare companies.
His career includes tenure at Deutsche Morgan Grenfell, where he served as Managing Director, responsible for international healthcare banking transactions; at Prudential Bache Capital Funding, where he was hired as Managing Director to start and manage its Healthcare Corporate Finance Group; at Montgomery Securities, where he was a General Partner and Co‐Founder of Montgomery Medical Ventures, and at L.F. Rothschild Unterberg Towbin, where he was a First Team Institutional Investor ranked hospital supply medical device analyst.
During his career Robert has represented and worked with numerous leading US and European Medical Device companies including such companies as: Bausch & Lomb, Baxter International, B Braun Melsungen AG, Beecham Plc, Beiersdorf AG, ConvaTec Inc, Fresenius-Kabi AG, Instrumentarium OY, Intergra Life Sciences Inc, L'Oreal, Mallinckrodt Inc, Merit Medical Systems, Seton Healthcare Group Ltd.Teleflex Inc., Warner Lambert and Wyeth.
Robert has served as a member of the Board of Directors of: MaxiCare Health Plans, Inc., Alta Bates Hospital and Health Care Corporation (Berkley, CA), The Mount Zion Hospital and Medical Center (San Francisco), and The Health Plan of California. He is a member of the American Hospital Association ("AHA"), The Hospital Financial Management Association("HFMA") and a founding member of The American Society of Parenteral and Enteral Nutrition ("ASPEN) as well as a Fellow of The Institute of Directors in London.
Robert has been involved with The Children's Health Fund as a board member for over 20 years, helping serve a population with high incidence of diabetes and recognizing the need for better patient care in this space.